Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma.
M BlaiseF RocherH SpittlerA SanchezE LanteriL CocoA PumaA MartelG GonfrierThierry PasseronHenri MontaudiéPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)